1. Home
  2. DNTH vs QBTS Comparison

DNTH vs QBTS Comparison

Compare DNTH & QBTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

N/A

Current Price

$89.30

Market Cap

5.9B

Sector

Health Care

ML Signal

N/A

Logo D-Wave Quantum Inc.

QBTS

D-Wave Quantum Inc.

N/A

Current Price

$16.54

Market Cap

6.4B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
DNTH
QBTS
Founded
2015
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
6.4B
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
DNTH
QBTS
Price
$89.30
$16.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
17
Target Price
★ $140.80
$34.65
AVG Volume (30 Days)
660.0K
★ 13.3M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $2,036,000.00
N/A
Revenue This Year
N/A
$72.74
Revenue Next Year
N/A
$89.80
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$32.28
$12.75
52 Week High
$117.88
$46.75

Technical Indicators

Market Signals
Indicator
DNTH
QBTS
Relative Strength Index (RSI) 35.61 44.14
Support Level $89.21 $12.75
Resistance Level $91.04 $19.01
Average True Range (ATR) 4.60 0.88
MACD -1.13 0.04
Stochastic Oscillator 23.83 18.95

Price Performance

Historical Comparison
DNTH
QBTS

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

About QBTS D-Wave Quantum Inc.

D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.

Share on Social Networks: